- Novavax, Takeda to develop COVID-19 vaccine candidate in Japan
- ImmVira, Shanghai Pharma to commercialize novel immunotherapies
- “Emerging evidence reports saliva sampling is more sensitive than nasopharyngeal swabs”
- AstraZeneca inks COVID-19 vaccine deal with China's BioKangtai
- Japan's Olympus acquires Arc Medical Design to expand therapeutic device offerings
- Asahi Kasei to commercialize HA nanogel as pharmaceutical excipient
- Colorcon opens new technical centre in Melbourne
- TB Alliance announces EC authorisation of new treatment for DR-TB
- NTU, A*STAR develop new way to deliver more drugs through skin
- Thailand pushing genomics project as centre of medical hub
- GenScript Biotech Corporation enters strategic distributor partnership with Premas Life Sciences to distribute cPassTM SARS CoV-2 Neutralization Antibody Detection Kit in India.
- Regulations and geopolitics themes for Japanese companies to reduce dependence on China
- "Transitioning to future with stronger APAC healthcare ecosystem"
- "Empowering APAC healthcare delivery framework through smart innovations"
-
Premium Article | 04 July 2020 | Influencers
We see already a higher awareness of why life science needs to be a priority for Japan and Australia
" The challenges with pandemic showed how resilient we are as an organization. The whole team in Ja...Read more
-
China | 07 August 2020 | News
ImmVira, Shanghai Pharma to commercialize novel immunotherapies
ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboratio...Read more
-
Singapore | 07 August 2020 | News
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK), a leading global biotechnology c...Read more
-
World | 05 March 2020 | News
FDA bans ESDs for self injurious behaviour
After careful consideration, the U.S. Food and Drug Administration (FDA) has published a final rule to ban ele...Read more
-
Europe | 06 March 2020 | News
Viroclinics Biosciences and DDL Diagnostic Lab join forces
Netherlands based Viroclinics Biosciences, a leading virology contract research organization, has announced th...Read more
Investing to control infectious diseases for future generations
Be it the Ebola epidemic in 2013 or the Zika outbreak in 2015 or more recently the coronavirus COVID-19 pandemic, infectious diseases are on the rise. The World Health Organization (WHO) states that infectious diseases kill more than 17 million people a year. 22 new diseases have emerged in the last 30 years. According to the vital signs report by the Centers for Disease Control and Prevention (CDC), illnesses from mosquito, tick and flea bites have tripled during the 13 years from 2004 through 2016. What can be done to prevent and manage the infectious diseases? Let’s find out.
